{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T13:46:38Z","timestamp":1725630398734},"reference-count":27,"publisher":"American Psychiatric Association Publishing","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[1965,3]]},"DOI":"10.1176\/ajp.121.9.911","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T18:31:16Z","timestamp":1418841076000},"page":"911-914","source":"Crossref","is-referenced-by-count":16,"title":["VISUAL HALLUCINATIONS WITH IMIPRAMINE"],"prefix":"10.1176","volume":"121","author":[{"given":"DONALD F.","family":"KLEIN","sequence":"first","affiliation":[{"name":"Senior Staff Psychiatrist, Research Department, Hillside Hospital, Glen Oaks, N. Y."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"p_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-113-28332"},{"key":"p_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1964.01720210044006"},{"key":"p_4","volume-title":"Diagnostic and Statistical Manual: Mental Disorders","author":"American Psychiatric Association","year":"1952"},{"key":"p_5","doi-asserted-by":"publisher","DOI":"10.1037\/10638-000"},{"key":"p_6","doi-asserted-by":"publisher","DOI":"10.1214\/aoms\/1177732543"},{"key":"p_7","doi-asserted-by":"publisher","DOI":"10.2307\/3001478"},{"key":"p_9","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1964.01720240008002"},{"key":"p_13","volume-title":"small proportion","author":"Post"},{"key":"p_14","volume-title":"Research Department"},{"key":"p_15","unstructured":"Aided in part by grants MH 02715, MH 04798, and MH 08004 of the National Institute of Mental Health, United States Public Health Service. The cooperation of Geigy Pharmaceuticals is gratefully acknowledged. hallucinations. Treatment could be continued at reduced dosage. Stoller(5) reports one case ( of 80) with \"hallucinations of sight and hearing.\" His dosage schedule ranged from 125 mg. to 400 mg. daily. Delay and Denilcer(6), reporting on 167 patients, state, \"In 3 patients episodes of dream-like confusion occurred on a dosage of 250 to 300 mg. per day. On decreasing the dosage the symptoms disappeared in 2 cases (one male aged 49 and one female aged 65). In the third case, an arteriopathic woman of 56, renewed treatment caused rep#{231}ated hallucinatory disorders. It should be noted that 3 other patients reported visual hallucinations, clearer with the eyes closed and occurring mostly before falling asleep (colors, small human forms, landscapes) .\" Lehmann, Cahn, and deVerteuil(7) report \"visual hallucinations\" in 5 of 84 patients with an average age of 57 receiving 200 mg. to 600 mg. daily. Confusion was not noted."},{"key":"p_17","unstructured":"Twelve patients reported visual hallucinations; 11 were receiving 300 mg. daily at the time. Total period of drug administration before onset of hallucinations ranged from 25-60 days with a median of 34. One case developed visual hallucina. tions after 6 days at a dose of 150 mg.\/day. The onset of hallucinations did not occur during periods of psychotic exacerbation, since there was no concomitant increase in delusions, agitation, or cognitive disorganization in any of the patients ; they expressed only a very mild anxious concern over their visual experiences. This concern responded with surprising ease to simple reassurance. The confusion approximating an organic mental syndrome reported by others was not apparent."},{"key":"p_22","volume-title":"faces, little children and women kneeling"},{"key":"p_23","unstructured":"In 9 of the 12 patients the phenomena were dosage dependent, as a decrease to 150-200 mg.\/day sufficed to terminate the visual hallucinations. In the one patient who developed hallucinations on 150 mg.\/ day, drug termination was necessary. In one patient who had hallucinated a black spot metamorphosing into a face, drug termination was followed by several days of seeing spiders, bugs and people all over the room accompanied by indistinct auditory hallucinations on awakening. This patient had a history of nocturnal visual hallucinations as a child. The third patient who had reported complete formed hallucinations of his grandfather accompanied by auditory hallucinations refused to discuss these phenomena."},{"key":"p_32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5161.1252-a"},{"key":"p_33","first-page":"160","volume":"4","author":"Cameron D.","year":"1959","journal-title":"Canad. Psychiat. Ass. J."},{"key":"p_34","first-page":"609","volume":"1","author":"Kielholz P.","year":"1959","journal-title":"Neuropsychopharmacology"},{"key":"p_35","first-page":"22","volume":"32","author":"Hanson L. C. F.","year":"1961","journal-title":"Nervenarzt"},{"key":"p_36","first-page":"1960","volume":"412","author":"Stoller","journal-title":"Med. J. Australia"},{"key":"p_37","first-page":"5100","volume":"4","author":"Delay J.","year":"1959","journal-title":"Canad. Psychiat. Ass. J."},{"key":"p_39","volume-title":"155","author":"Ass J.","year":"1958"},{"key":"p_40","doi-asserted-by":"crossref","unstructured":"Stratton, 1962.","DOI":"10.1017\/S0272503700028652"},{"key":"p_41","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-196406000-00002"},{"key":"p_42","volume-title":"The Cerebral Cortex of Man","author":"Penfield W.","year":"1950"},{"key":"p_43","volume-title":"L","author":"Malitz"},{"key":"p_45","volume-title":"Studies in Personality","author":"Kluver H.","year":"1942"},{"key":"p_50","volume-title":"Chief, Female Continued Treatment Services, and Chief, Clinical Pathological Laboratory, Dr."},{"key":"p_52","volume-title":"1958, 50 patients of Dr.","author":"Method"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.121.9.911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T14:50:16Z","timestamp":1722178216000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.121.9.911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1965,3]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1965,3]]}},"alternative-id":["10.1176\/ajp.121.9.911"],"URL":"https:\/\/doi.org\/10.1176\/ajp.121.9.911","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[1965,3]]}}}